Wondering about the most recent progress in Myasthenia Gravis treatments research and clinical trials?
Wondering about the most recent progress in myasthenia gravis treatments research and clinical trials?
Join a “What’s New in MG Research” webinar to learn about the latest research results, key clinical trial phases, and current outcomes from top research trials taking place right now.
Pioneering RNA Cell Therapy for Autoimmune Diseases
Wednesday, October 22 @ 2:00 PM Eastern Time (US and Canada)
Descartes-08 is an RNA cell therapy designed to target immune cells which produce autoantibodies directly responsible for symptoms of myasthenia gravis and other autoimmune diseases. In a Phase 2b randomized controlled trial in adults with generalized myasthenia gravis, participants who received Descartes-08 had significant improvement in symptoms compared to placebo, which was maintained through 12 months of follow-up. In this webinar, we will discuss the results of this recently completed trial, as well as the ongoing Phase 3 trial of Descartes-08 in MG (AURORA).
Register Now
This webinar is brought to you by Cartesian Therapeutics.
Presenting Partners
Recent Webinars
